In the global biotech and pharmaceutical sectors, the definition of success is undergoing a fundamental transformation. As of 2026, corporate performance is no longer measured solely by revenue and profit margins; ESG (Environmental, Social, and Governance) performance has officially moved from a “nice-to-have” social responsibility to a core financial requirement.

As IFRS S1 and S2 integrate sustainability into financial frameworks, “climate risks” and “transition costs” are no longer hidden—they are now front and center. In the near future, a company’s carbon reduction capability will directly dictate its market valuation, competitive edge for orders, and financing costs.
According to reporting from Commercial Times, the shift marks a “green revolution” in corporate reporting:
At TCI, we stayed ahead of the curve long before the rules changed. While the industry is now adjusting to these new standards, our commitment has been in motion for years. Since joining RE100 in 2018, we have committed to 100% renewable energy by 2030. This is more than a slogan; it is our pledge to the planet and our role as a steadfast “Net-Zero Backbone” for our global partners.
For biotech firms and CDMOs, high-energy manufacturing is now a competitive liability unless managed with a clear green strategy. At TCI, we don’t just manufacture health products; we are building a sustainable future. In this new era, the competitive landscape is being rewritten. Future industry leaders will be those who demonstrate not just high EPS (Earnings Per Share), but also high governance maturity and a rapid green transition. TCI remains dedicated to providing the sustainable infrastructure our partners need to thrive in a Net-Zero world.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
We will get back to you soon. Thank you.
Thank you for your response. We’ll keep you informed about future TCI events and updates.